Workplace drug testing is a standard part of employment across many industries — from healthcare and transportation to manufacturing and government. Whether you are an employer building a compliant testing program or an employee preparing for a pre-employment screen, understanding how the process works removes the uncertainty and helps everyone involved move forward with confidence.
Why Employers Test
Drug testing programs serve multiple legitimate purposes for employers:
- Safety: Impairment from drugs or alcohol creates serious risks in any environment involving machinery, vehicles, patients, or hazardous materials
- Liability reduction: A documented testing program demonstrates due diligence and can limit employer liability in the event of a workplace incident
- Regulatory compliance: Many industries — transportation, aviation, nuclear, and others — require testing by federal law
- Productivity and culture: Testing programs often reduce absenteeism, accidents, and turnover
Common Drug Test Panel Types
5-Panel Test
The standard for most non-DOT workplace testing. Screens for marijuana (THC), cocaine, opiates, amphetamines, and phencyclidine (PCP). This is the panel used in most pre-employment and random testing programs.
10-Panel Test
Adds five additional substances to the 5-panel: benzodiazepines, barbiturates, methadone, propoxyphene, and methaqualone. Often used in healthcare, law enforcement, and positions involving prescription medications.
Extended Panels
Employers may customize panels to include additional substances such as synthetic opioids (fentanyl, buprenorphine), synthetic cannabinoids, or alcohol depending on their industry and risk profile.
Collection Methods
Urine Testing
Urine is the most common and widely accepted specimen type for workplace drug testing. It provides a detection window of days to weeks depending on the substance and frequency of use. All federally mandated DOT testing uses urine.
Oral Fluid (Saliva) Testing
Oral fluid testing offers a shorter detection window — generally hours to one to two days — which makes it particularly effective for detecting recent use. It is gaining adoption in workplace programs because collection is observed and less invasive than urine collection.
Hair Testing
Hair testing provides a much longer detection window — up to 90 days — and is used in some employment programs where historical drug use is relevant. It is not currently accepted for federally mandated DOT testing.
Chain of Custody
Chain of custody (COC) is the documented process that ensures a specimen has not been tampered with or misidentified from the moment of collection to the moment results are reported. For legally defensible testing, every step must be documented:
- Collector verifies donor identity with photo ID
- Specimen is collected and labeled in the donor's presence
- Donor and collector sign the chain of custody form
- Specimen is sealed and shipped to a SAMHSA-certified laboratory
- Laboratory analyzes the specimen and reports results to a Medical Review Officer (MRO)
- MRO reviews results and contacts the donor before reporting any positive to the employer
The Medical Review Officer is a licensed physician who reviews all non-negative results before reporting to an employer. They contact the donor to determine whether a legitimate medical explanation exists — such as a prescription medication — before a result is finalized. This protects employees from unfair outcomes.
What Employees Should Know
You Have Rights
Before a positive result is reported to your employer, the MRO will contact you directly. You have the right to provide documentation of any prescriptions that may explain the result. This step exists specifically to protect employees.
Prescription Medications
A valid prescription does not automatically mean a positive result will be canceled — the MRO evaluates whether the prescribed medication is consistent with the test result and whether it creates a safety concern in your role. Be honest and proactive in providing documentation.
Split Specimen Testing
When you provide a urine sample, it is split into two bottles. If your primary specimen tests positive and you dispute the result, you have the right to request that the second bottle be tested at a different SAMHSA-certified laboratory at your own expense.
Turnaround Time
A negative result is typically reported within 24–48 hours. Non-negative results require laboratory confirmation testing (GC/MS) and MRO review, which typically adds two to five business days. Rush processing is available at some facilities for time-sensitive hiring decisions.